165 related articles for article (PubMed ID: 37313653)
1. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment.
Li L; Yu L; Xu Z; Wei L; Zhang B; Han X; Sun Y; Ma L
J Cosmet Dermatol; 2023 Dec; 22(12):3369-3374. PubMed ID: 37313653
[TBL] [Abstract][Full Text] [Related]
2. Multiple cutaneous and hepatic infantile hemangiomas having a successful response to propranolol as monotherapy at neonatal period.
Cavalli R; Novotna V; Buffon RB; Gelmetti C
G Ital Dermatol Venereol; 2013 Oct; 148(5):525-30. PubMed ID: 24005146
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma.
Wang L; Li J; Song D; Guo L
Pediatr Surg Int; 2022 Aug; 38(8):1149-1155. PubMed ID: 35708761
[TBL] [Abstract][Full Text] [Related]
4. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Yu Z; Cai R; Chang L; Qiu Y; Chen X; Chen Q; Ma G; Jin Y; Lin X
J Dermatol; 2019 May; 46(5):376-382. PubMed ID: 30916822
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid.
López-Gutiérrez JC
Eur J Pediatr; 2019 Jan; 178(1):1-6. PubMed ID: 30421264
[TBL] [Abstract][Full Text] [Related]
6. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases.
Sagi L; Zvulunov A; Lapidoth M; Ben Amitai D
Dermatology; 2014; 228(2):136-44. PubMed ID: 24556822
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
9. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
10. The role of propranolol in the treatment of infantile hemangioma.
Laranjo S; Costa G; Paramés F; Freitas I; Martins JD; Trigo C; Pinto FF
Rev Port Cardiol; 2014 May; 33(5):289-95. PubMed ID: 24906291
[TBL] [Abstract][Full Text] [Related]
11. [Infantile hemangioma and propranolol: a therapeutic "revolution". Literature review].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2013; 34(6):479-84. PubMed ID: 24505868
[TBL] [Abstract][Full Text] [Related]
12. Screening for infantile hepatic hemangioma in patients with cutaneous infantile hemangioma: A multicenter prospective study.
Ji Y; Chen S; Yang K; Xiang B; Jiang X; Xu X; Li L; Qiu T; Zhou J; Dai S; Zhang X; Lu G; Kong F; Yang G; Qiu Q
J Am Acad Dermatol; 2021 May; 84(5):1378-1384. PubMed ID: 33285272
[TBL] [Abstract][Full Text] [Related]
13. [Infantile haemangioma: an update].
Reimer A; Ott H
Hautarzt; 2019 Jun; 70(6):447-458. PubMed ID: 31101924
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
[TBL] [Abstract][Full Text] [Related]
15. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
16. Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions.
Hermans DJ; Bauland CG; Zweegers J; van Beynum IM; van der Vleuten CJ
Br J Dermatol; 2013 Apr; 168(4):837-43. PubMed ID: 23278381
[TBL] [Abstract][Full Text] [Related]
17. [Infantile hemangioma: a new indication for propranolol? Retrospective study: a case-series of 25 infants].
Yilmaz L; Dangoisse C; Semaille P
Rev Med Brux; 2015; 36(1):3-9. PubMed ID: 25856965
[TBL] [Abstract][Full Text] [Related]
18. Infantile hemangioma: Efficacy of low-dose propranolol and of intralesional bleomycin injection for propranolol non-response.
Düzenli Kar Y; Özdemir ZC; Acu B; Bör Ö
Pediatr Int; 2019 May; 61(5):459-464. PubMed ID: 30861274
[TBL] [Abstract][Full Text] [Related]
19. Does treatment with propranolol affect quality of life in infantile hemangioma patients and their parents?
de Wild SR; Moyakine AV; van der Vleuten CJM
Pediatr Dermatol; 2019 Nov; 36(6):958-960. PubMed ID: 31566792
[TBL] [Abstract][Full Text] [Related]
20. Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser.
Reddy KK; Blei F; Brauer JA; Waner M; Anolik R; Bernstein L; Brightman L; Hale E; Karen J; Weiss E; Geronemus RG
Dermatol Surg; 2013 Jun; 39(6):923-33. PubMed ID: 23458381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
